For what diagnoses are psychotropic medications being prescribed?: A nationally representative survey of physicians

CNS Drugs

Volumn 24, Issue 4, 2010, Pages 319-326

  Mark, Tami L ^a  

^a THOMSON REUTERS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; NEUROLEPTIC AGENT;

ADJUSTMENT DISORDER; ALLERGIC REACTION; AMNESIA; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; BENIGN TUMOR; BIPOLAR DISORDER; COGNITIVE DEFECT; CONDUCT DISORDER; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CONVULSION; DEGENERATIVE DISEASE; DELIRIUM; DEMENTIA; DEPRESSION; DEVELOPMENTAL DISORDER; DIABETES MELLITUS; DISRUPTIVE BEHAVIOR; DIZZINESS; DRUG DEPENDENCE; ENDOCRINE DISEASE; EPILEPSY; GASTROINTESTINAL HEMORRHAGE; GENETIC DISORDER; GYNECOLOGIC DISEASE; HEADACHE; HUMAN; IMPULSE CONTROL DISORDER; INTERVERTEBRAL DISK DISEASE; MENTAL DISEASE; METABOLIC DISORDER; MIGRAINE; MOOD DISORDER; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; NUTRITIONAL DISORDER; PERSONALITY DISORDER; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SKIN DISEASE; SKIN INFLAMMATION; SPONDYLOSIS; SPRAIN; VERTIGO;

DRUG PRESCRIPTIONS; DRUG UTILIZATION; HEALTH CARE SURVEYS; HUMANS; MENTAL DISORDERS; PHYSICIAN'S PRACTICE PATTERNS; PSYCHOTROPIC DRUGS; UNITED STATES;

EID: 77949582280     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.2165/11533120-000000000-00000     Document Type: Article

References (17)

1. Lamb E. Top 200 prescription drugs of 2006 [online]. Avail-able from URL: http://wwwpharmacytimescom/issue/phar macy/2007/2007-05/2007-05-6472 [Accessed 2009 Jun 19]
2. Mark TL, Levit KR, Buck JA, et al. Mental health treatment expenditure trends, 1986-2003. Psychiatr Serv 2007 Aug; 58 (8): 1041-1048
3. Zuvekas SH. Prescription drugs and the changing patterns of treatment for mental disorders, 1996-2001. Health Aff (Millwood) 2005 Jan-Feb; 24 (1): 195-205
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994
5. International Classification of Diseases, Version 9, Clinical Modification (ICD-9-CM). Washington, DC: Health and Human Services Department, Centers for Disease Control and Prevention, Centers for Medicare and Medicaid Services, 2009
6. Centers for Disease Control and Prevention National Center for Health Statistics. National Ambulatory Medical Care Survey 2005 [online]. Available from URL: http://www. cdc.gov/nchs/ahcd/ahcd-questionnaires.htm [Accessed 2009 Aug 10]
7. Elixhauser A, Steiner CA, Whittington C. Clinical classifi-cations for health policy research: hospital inpatient statistics, 1995 [online]. Healthcare Cost and Utilization Project, HCUP 3 Research Note. Rockville (MD): Agency for Health Care Policy and Research, 1998: AHCPR Pub. No.98-0049. Available from URL: http://www.hcup-us.ahrq. gov/reports/natstats/his95.htm [Accessed 2009 Jun 19]
8. Radley DC, Finkelstein SN, Stafford RS. Off-label pre-scribing among office-based physicians. Arch Intern Med 2006 May 8; 166 (9): 1021-1026
9. Rosak J. AMA calls for studies of psychotropic use in chil-dren: psychiatric news 2001 [online]. Available from URL: http:// pnpsychiatryonlineorg/cgi/content/full/36/2/2 [Accessed 2009 Jun 19]
10. Health Day (Medline Plus). FDA panel OKs newer anti-psychotics for children [online]. Available from URL: http://www.nlm.nih.gov/medlineplus/news/ fullstory-85467. html [Accessed 2009 Jun 19]
11. Salzman C, Jeste DV, Meyer RE, et al. Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy. J Clin Psychiatry 2008 Jun; 69 (6): 889-898
12. Ballard C, Hanney ML, Theodoulou M, et al. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol 2009 Feb; 8 (2): 151-157
13. Elkashef AM, Rawson RA, Anderson AL, et al. Bupropion for the treatment of methamphetamine dependence. Neuro-psychopharmacology 2008 Apr; 33 (5): 1162-1170
14. Elkashef A, Vocci F, Huestis M, et al. Marijuana neuro-biology and treatment. Subst Abuse 2008; 29 (3): 17-29
15. Dwoskin LP, Rauhut AS, King-Pospisil KA, et al. Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. CNS Drug Rev 2006 Fall-Winter; 12 (3-4): 178-207
16. Nellissery M, Feinn RS, Covault J, et al. Alleles of a func-tional serotonin transporter promoter polymorphism are associated with major depression in alcoholics. Alcohol Clin Exp Res 2003 Sep; 27 (9): 1402-1408
17. Pettinati HM, Volpicelli JR, Kranzler HR, et al. Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype. Alcohol Clin Exp Res 2000 Jul; 24 (7): 1041-1049